Home / Liver models

CELLBLOKS® Liver models

Enhance drug metabolism studies and safety screening with CELLBLOKS®  3D Stack Liver-on-a-chip  models

CELLBLOKS® Liver models

Drug-induced liver injury (DILI) remains the leading cause of attrition in all phases of clinical trials and the primary cause of post-market drug withdrawal. Our CELLBLOKS® liver-on-a-chip models are the only industry-compliant platforms that combine high-throughput capability with in-vivo relevance. Featuring precise 3-D structural arrangements of various cell types resembling liver structure, our models promote intercellular communication and in-vivo-like metabolic function, enabling the prediction of adverse drug effects with exceptional accuracy. With our technology, you can generate high-quality, human-relevant data in a rapid, cost-effective manner


Physiologically relevant

Constitutes key liver cell types including hepatocytes , fibroblasts and endothelial cells allowing cell-cell interactions

Liver functionality

Enhanced hepatic relevance including increased albumin, urea and Cytochrome P450 production compared to standard hepatocyte mon-cultures

Industry compliant

The platform is designed in a standard SBS plate format compatible with standard imaging and readout equipment

Open access

Direct access to liver cell layers and compounds can be directly added to the model. Each layer can be independetly removed from the model

Ready to use

Use Liver-on-a-Chip model directly after arrival for up to 14 days allowing you to perform your studies straight away

Flow enabled 

Use with or without media flow circulation
Optimised cell maintenance medium provided

Media flow enabled via gravity-driven perfusion

Dynamic media flow around and through the cell-layers enabling continues supply of nutrients and oxygen to the cells replicating liver tissue microenvironment 

Liver Models Available 

Primary Heptocyte 3D Stack co-culture Model

Perform rapid and reliable drug screening with our tri-culture chip model, composed of HepG2 cells, human endothelial HUVEC cells, and fibroblast cells grown in layered scaffold blocks. This enables high-throughput and reproducible drug screening, allowing for the rapid identification of potential drug candidates.

Learn more

HepG2 3D Stack co-culture Model

Enhance your drug screening results with our primary cell-derived liver model composed of hepatocytes and NPC cells, providing a more physiologically relevant and predictive system for drug safety and efficacy assessment. Try it now and get more reliable and accurate data for your drug development

Learn more

Frequency Bought Together